We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $550B
1-Year Est. Return 43.33%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+29.03%
1 Year Est. Return
+43.33%
3 Year Est. Return
+132.06%
5 Year Est. Return
+165.07%
10 Year Est. Return
+656.77%
AUM
$550B
AUM Growth
+$69.1B
Cap. Flow
-$11.9B
Cap. Flow %
-2.17%
Top 10 Hldgs %
32.74%
Holding
3,886
New
45
Increased
996
Reduced
1,636
Closed
163
Avg Time Held
20.5 quarters
Top 10 Avg Time Held
10.6 quarters
Top 20 Avg Time Held
17.9 quarters

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$1.73B
2
ETN icon
Eaton
ETN
+$1.21B
3
STX icon
Seagate
STX
+$1.1B
4
TT icon
Trane Technologies
TT
+$1.02B
5
ACN icon
Accenture
ACN
+$1.01B

Sector Composition

Rank Sector Weight
1 Technology 40.05%
2 Financials 11.12%
3 Healthcare 9.54%
4 Consumer Discretionary 9.09%
5 Communication Services 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DPG
3526
Duff & Phelps Utility and Infrastructure Fund
DPG
$468M
$1.69K ﹤0.01%
114
– –
2025 Q4
2 quarters
III icon
3527
Information Services Group
III
$280M
$1.69K ﹤0.01%
411
– –
2026 Q1
1 quarter
OEC icon
3528
Orion
OEC
$326M
$1.68K ﹤0.01%
254
– –
2026 Q1
1 quarter
REMG
3529
Russell Investments Emerging Markets Equity ETF
REMG
$124M
$1.68K ﹤0.01%
45
– –
2026 Q1
1 quarter
CDZI icon
3530
Cadiz
CDZI
$290M
$1.66K ﹤0.01%
398
– –
2025 Q4
2 quarters
ASIC
3531
Ategrity Specialty Insurance
ASIC
$1.24B
$1.64K ﹤0.01%
68
– –
2026 Q1
1 quarter
WFG icon
3532
West Fraser Timber
WFG
$5.03B
$1.63K ﹤0.01%
24
– –
2026 Q1
1 quarter
METCB icon
3533
Ramaco Resources Class B
METCB
$284M
$1.62K ﹤0.01%
194
-2
-1% -$20
2025 Q4
2 quarters
FPH icon
3534
Five Point Holdings
FPH
$322M
$1.61K ﹤0.01%
306
– –
2026 Q1
1 quarter
PKOH icon
3535
Park-Ohio Holdings
PKOH
$710M
$1.58K ﹤0.01%
41
– –
2025 Q4
2 quarters
NIQ
3536
NIQ Global Intelligence PLC
NIQ
$5.34B
$1.57K ﹤0.01%
168
-68,500
-100% -$662K
2025 Q4
2 quarters
SB icon
3537
Safe Bulkers
SB
$971M
$1.56K ﹤0.01%
248
– –
2026 Q1
1 quarter
TU icon
3538
Telus
TU
$12.2B
$1.56K ﹤0.01%
148
– –
2026 Q1
1 quarter
EDIT icon
3539
Editas Medicine
EDIT
$445M
$1.55K ﹤0.01%
480
– –
2026 Q1
1 quarter
CRD.A icon
3540
Crawford & Co Class A
CRD.A
$609M
$1.53K ﹤0.01%
136
– –
2026 Q1
1 quarter
VABK icon
3541
Virginia National Bankshares
VABK
$263M
$1.51K ﹤0.01%
34
– –
2026 Q1
1 quarter
MDWD icon
3542
MediWound
MDWD
$162M
$1.49K ﹤0.01%
101
– –
2026 Q1
1 quarter
NXH
3543
Neighborhood Intelligence Inc
NXH
$186M
$1.46K ﹤0.01%
252
– –
2026 Q1
1 quarter
THRY icon
3544
Thryv Holdings
THRY
$62.7M
$1.44K ﹤0.01%
366
– –
2021 Q4
18 quarters
DMAC icon
3545
DiaMedica Therapeutics
DMAC
$449M
$1.43K ﹤0.01%
203
– –
2025 Q4
2 quarters
CADL icon
3546
Candel Therapeutics
CADL
$761M
$1.42K ﹤0.01%
138
– –
2026 Q1
1 quarter
BBNX
3547
Beta Bionics
BBNX
$951M
$1.38K ﹤0.01%
88
– –
2025 Q4
2 quarters
PRTH icon
3548
Priority Technology Holdings
PRTH
$644M
$1.36K ﹤0.01%
204
– –
2026 Q1
1 quarter
RVSB icon
3549
Riverview Bancorp
RVSB
$119M
$1.35K ﹤0.01%
248
– –
2026 Q1
1 quarter
ATEX icon
3550
Anterix
ATEX
$1.66B
$1.34K ﹤0.01%
13
– –
2025 Q4
2 quarters

Similar funds

UBS AM's Q2 2026 Portfolio in Review

As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
  • UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
  • UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
  • UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
  • UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
  • UBS AM opened 45 new positions and closed 163 in Q2 2026.
  • UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.